Solasia Pharma K.K. (4597.T)

JPY 42.0

(2.44%)

Total Debt Summary of Solasia Pharma K.K.

  • Solasia Pharma K.K.'s latest annual total debt in 2023 was 60 Million JPY , up 62.16% from previous year.
  • Solasia Pharma K.K.'s latest quarterly total debt in 2024 Q2 was 44 Million JPY , down -92.06% from previous quarter.
  • Solasia Pharma K.K. reported annual total debt of 37 Million JPY in 2022, down -55.95% from previous year.
  • Solasia Pharma K.K. reported annual total debt of 84 Million JPY in 2021, down -92.08% from previous year.
  • Solasia Pharma K.K. reported quarterly total debt of 554 Million JPY for 2024 Q1, up 823.33% from previous quarter.
  • Solasia Pharma K.K. reported quarterly total debt of 60 Million JPY for 2023 Q4, down -13.04% from previous quarter.

Annual Total Debt Chart of Solasia Pharma K.K. (2023 - 2013)

Historical Annual Total Debt of Solasia Pharma K.K. (2023 - 2013)

Year Total Debt Total Debt Growth
2023 60 Million JPY 62.16%
2022 37 Million JPY -55.95%
2021 84 Million JPY -92.08%
2020 1.06 Billion JPY 1458.82%
2019 68 Million JPY 0.0%
2018 - JPY 0.0%
2017 - JPY 0.0%
2016 - JPY -100.0%
2015 2.86 Billion JPY 116.98%
2014 1.32 Billion JPY 165.66%
2013 497.41 Million JPY 0.0%

Peer Total Debt Comparison of Solasia Pharma K.K.

Name Total Debt Total Debt Difference
Pharma Foods International Co., Ltd. 16.89 Billion JPY 99.645%
Takeda Pharmaceutical Company Limited 4843.75 Billion JPY 99.999%
Sumitomo Pharma Co., Ltd. 418.88 Billion JPY 99.986%
Shionogi & Co., Ltd. 11.62 Billion JPY 99.484%
Wakamoto Pharmaceutical Co.,Ltd. 100.52 Million JPY 40.316%
Nippon Shinyaku Co., Ltd. 2.87 Billion JPY 97.911%
Kaken Pharmaceutical Co., Ltd. 3.85 Billion JPY 98.442%
Eisai Co., Ltd. 206.74 Billion JPY 99.971%
Morishita Jintan Co., Ltd. 425 Million JPY 85.882%
Hisamitsu Pharmaceutical Co., Inc. 2.1 Billion JPY 97.143%
Mochida Pharmaceutical Co., Ltd. 369 Million JPY 83.74%
Fuso Pharmaceutical Industries,Ltd. 12.72 Billion JPY 99.528%
Nippon Chemiphar Co., Ltd. 16.98 Billion JPY 99.647%
Tsumura & Co. 79.69 Billion JPY 99.925%
Kissei Pharmaceutical Co., Ltd. 1.72 Billion JPY 96.526%
Torii Pharmaceutical Co., Ltd. 244 Million JPY 75.41%
Towa Pharmaceutical Co., Ltd. 202.35 Billion JPY 99.97%
Fuji Pharma Co., Ltd. 28.94 Billion JPY 99.793%
Zeria Pharmaceutical Co., Ltd. 47.58 Billion JPY 99.874%
KYORIN Holdings, Inc. 20.94 Billion JPY 99.714%
Taiko Pharmaceutical Co.,Ltd. 3.8 Billion JPY 98.425%
Daito Pharmaceutical Co.,Ltd. 8.71 Billion JPY 99.312%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Modalis Therapeutics Corporation 412.5 Million JPY 85.455%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.48 Billion JPY 99.367%
Sawai Group Holdings Co., Ltd. 82.89 Billion JPY 99.928%
Cyfuse Biomedical K.K. 913 Million JPY 93.428%
Toho Holdings Co., Ltd. 30.24 Billion JPY 99.802%
Koa Shoji Holdings Co.,Ltd. 2.82 Billion JPY 97.876%